EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An adenosinergic positive feedback loop extends pharmacological cardioprotection duration

Gerald Wölkart iD, Simon Gissing, Heike Stessel, Erin K Fassett, Burkhard Klösch, Robert W Greene, Bernd Mayer, John T Fassett iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.17331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Gerald Wölkart und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Adenosine, Cardiotonic Agents, Mice, Inbred C57BL, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Adenosine receptor activation induces delayed, sustained cardioprotection against ischaemia–reperfusion (IR) injury (24–72 h), but the mechanisms underlying extended cardioprotection duration remain unresolved. We hypothesized that a positive feedback loop involving adenosine receptor‐induced proteasomal degradation of adenosine kinase (ADK) and decreased myocardial adenosine metabolism extends the duration of cardioprotection. Experimental Approach Mice were administered an ADK inhibitor, ABT‐702, to induce endogenous adenosine signalling. Cardiac ADK protein and mRNA levels were analysed 24–120 h later. Theophylline or bortezomib was administered 24 h after ABT‐702 to examine the late roles of adenosine receptors or proteasomal activity, respectively, in ADK expression and cardioprotection at 72 h. Coronary flow and IR tolerance were analysed by Langendorff technique. The potential for continuous adenosinergic cardioprotection was examined using heterozygous, cardiac‐specific ADK KO (cADK +/− ) mice. Cardiac ADK expression was also examined after A 1 or A 3 receptor agonist, phenylephrine, lipopolysaccharide or sildenafil administration. Key results ABT‐702 treatment decreased ADK protein content and provided cardioprotection from 24 to 72 h. ADK mRNA upregulation restored ADK protein after 96–120 h. Adenosine receptor or proteasome inhibition at 24 h reversed ABT‐702‐induced ADK protein deficit and cardioprotection at 72 h. cADK +/− hearts exhibited continuous cardioprotection. Diverse preconditioning agents also diminished cardiac ADK protein expression. Conclusion and Implications A positive feedback loop driven by adenosine receptor‐induced ADK degradation and renewed adenosine signalling extends the duration of cardioprotection by ABT‐702 and possibly other preconditioning agents. The therapeutic potential of continuous adenosinergic cardioprotection is demonstrated in cADK +/− hearts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineCardiotonic AgentsMice, Inbred C57BLMyocardial Reperfusion InjuryAdenosine KinaseFeedback, PhysiologicalAnimalsMaleMiceMice, KnockoutReceptors, Purinergic P1MyocardiumProteasome Endopeptidase ComplexMorpholinesPyrimidines

Stichwörter der Autor:innen

adenosineadenosine kinasecardiaccardioprotectionischaemiapreconditioning

Substanzen

AdenosineCardiotonic AgentsABT 702Adenosine KinaseReceptors, Purinergic P1Proteasome Endopeptidase ComplexMorpholinesPyrimidines

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, University of Graz, Graz, Austria.
  • Ludwig Boltzmann Institute for Arthritis and Rehabilitation, University of Graz, Graz, Austria.
  • Department of Psychiatry and Neuroscience, Peter O'Donnell Brain Institute, UTSW Medical Center, Dallas, Texas, USA.

ORCID-Profile: Gerald Wölkart, John T Fassett

Förderung

  • Austrian Science Fund FWF
  • Austrian Science Fund

Zitieren

APA

Wölkart, G., Gissing, S., Stessel, H., Fassett, E. K., Klösch, B., Greene, R. W., Mayer, B., & Fassett, J. T. (2024). An adenosinergic positive feedback loop extends pharmacological cardioprotection duration. British Journal of Pharmacology. https://doi.org/10.1111/bph.17331

Vancouver

Wölkart G, Gissing S, Stessel H, Fassett EK, Klösch B, Greene RW, et al. An adenosinergic positive feedback loop extends pharmacological cardioprotection duration. British Journal of Pharmacology. 2024. doi:10.1111/bph.17331

BibTeX
@article{Wlkart2024,
  author = {Wölkart, Gerald and Gissing, Simon and Stessel, Heike and Fassett, Erin K and Klösch, Burkhard and Greene, Robert W and Mayer, Bernd and Fassett, John T},
  title = {An adenosinergic positive feedback loop extends pharmacological cardioprotection duration},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.17331}
}
Kostenlos starten →